ImmuCell Corp Files 2024 Annual Report
Ticker: ICCC · Form: 10-K · Filed: Mar 28, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 10-k, diagnostics
Related Tickers: ICCC
TL;DR
ImmuCell filed its 2024 10-K. Stock symbol ICCC on Nasdaq.
AI Summary
ImmuCell Corporation filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware and headquartered in Portland, Maine, is involved in in vitro & in vivo diagnostic substances. Its common stock is traded on The Nasdaq Capital Market under the symbol ICCC.
Why It Matters
This filing provides investors with a comprehensive overview of ImmuCell Corporation's financial performance, business operations, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a standard annual financial filing with no immediate red flags or significant new disclosures.
Key Players & Entities
- IMMUCELL CORP /DE/ (company) — Filer
- 20241231 (date) — Fiscal Year End
- 0000811641 (company) — Central Index Key
- 2835 (industry_code) — Standard Industrial Classification
- 010382980 (ein) — EIN
- DE (state) — State of Incorporation
- 56 EVERGREEN DR (address) — Business Street 1
- PORTLAND (city) — Business City
- ME (state) — Business State
- 04103 (zip_code) — Business Zip
FAQ
What is the primary business of ImmuCell Corporation?
ImmuCell Corporation is involved in in vitro & in vivo diagnostic substances, as indicated by its Standard Industrial Classification code [2835].
Where is ImmuCell Corporation headquartered?
ImmuCell Corporation's principal executive offices are located at 56 Evergreen Drive, Portland, Maine 04103.
On which stock exchange is ImmuCell Corporation's common stock traded?
ImmuCell Corporation's common stock is traded on The Nasdaq Capital Market.
What is the trading symbol for ImmuCell Corporation's common stock?
The trading symbol for ImmuCell Corporation's common stock is ICCC.
For which fiscal year is this 10-K report filed?
This 10-K report is filed for the fiscal year ended December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding IMMUCELL CORP /DE/ (ICCC).